Patent · US Active

Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA

US7888325B2 · kind B2 · utility

6Cited by
64References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 12, 2006
Grant dateFeb 15, 2011
Priority date
Expiry dateNov 29, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Introduction of double stranded RNA into cells, cell culture, organs and tissues, and whole organisms, particularly vertebrates, specifically attenuates gene expression.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.